Susan Kais, MD
Gastroenterology · West Chester, OHNPI 1265607667
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $163,170 of the $219,951 with a category attached, or 74.2%. AbbVie accounts for 72.7% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $49,315, 2.3 times the $20,989 reported in 2019. Among gastroenterology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 318 payments — averaging $691.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$160K
- E.r. Squibb & Sons, L.L.C.$34K
- Johnson & Johnson$13K
- Takeda Pharmaceuticals U.S.A., Inc.$6K
- Janssen Scientific Affairs, LLC$3K
- Bristol Myers Squibb$2K
- plus $2K from 8 others
What the payments were for
- Consulting fees$17,5138%
- Speaking & faculty fees$163,17074%
- Travel & lodging$29,37713%
- Food & beverage$9,8074%
- Education$850%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 215 | $159,992 |
| E.r. Squibb & Sons, L.L.C. | 34 | $33,813 |
| Johnson & Johnson | 18 | $13,374 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $6,132 |
| Janssen Scientific Affairs, LLC | 1 | $2,625 |
| Bristol Myers Squibb | 9 | $2,139 |
| Pfizer | 1 | $950 |
| Lilly USA, LLC | 7 | $361 |
| QOL Medical, LLC | 5 | $217 |
| Conmed Corporation | 1 | $139 |
| Ferring Pharmaceuticals Inc. | 1 | $111 |
| Mentor Worldwide LLC | 1 | $69 |
| Biocon Biologics Inc | 1 | $16 |
| Sanofi | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$219,951 in reported general payments places this provider in the 95th percentile of 657 gastroenterology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 11 | $131,087 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 77 | $1,102 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 17 | $269 |
| Omeprazole | 23 | $204 |
| Pantoprazole Sodium | 13 | $204 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in West Chester
- Naim AlkhouriWestlake$1.9M
- Pierre GholamCleveland$1.6M
- Anita AfzaliCincinnati$798K
- Mohamed NaemWestlake$708K
- Kara de FeliceCincinnati$427K
- Tasos ManokasColumbus$411K
- Florian RiederCleveland$396K
- Allan PeckCincinnati$391K
- Dany RaadHighland Hills$387K
- Stanley CohenCleveland$338K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.